PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 47 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $7,822 | +429.6% | 42,742 | +426.6% | 0.00% | – |
| Q4 2023 | $1,477 | -84.0% | 8,116 | -73.7% | 0.00% | – |
| Q3 2023 | $9,209 | +126.2% | 30,904 | +26.0% | 0.00% | – |
| Q2 2023 | $4,071 | +31215.4% | 24,525 | +80.8% | 0.00% | – |
| Q1 2023 | $13 | +8.3% | 13,564 | +16.0% | 0.00% | – |
| Q4 2022 | $12 | -100.0% | 11,696 | -45.8% | 0.00% | – |
| Q3 2022 | $25,000 | – | 21,581 | +9665.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 221 | -73.4% | 0.00% | – |
| Q1 2022 | $3,000 | +50.0% | 832 | +108.0% | 0.00% | – |
| Q4 2021 | $2,000 | – | 400 | +19900.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 2 | -100.0% | 0.00% | -100.0% |
| Q2 2021 | $44,000 | +51.7% | 11,557 | +3.7% | 0.00% | – |
| Q1 2021 | $29,000 | -29.3% | 11,147 | -31.4% | 0.00% | -100.0% |
| Q4 2020 | $41,000 | -66.1% | 16,241 | -72.2% | 0.00% | 0.0% |
| Q3 2020 | $121,000 | +278.1% | 58,487 | +458.2% | 0.00% | 0.0% |
| Q2 2020 | $32,000 | +300.0% | 10,478 | +366.9% | 0.00% | 0.0% |
| Q4 2019 | $8,000 | +100.0% | 2,244 | +106.8% | 0.00% | – |
| Q3 2019 | $4,000 | -85.7% | 1,085 | -81.5% | 0.00% | -100.0% |
| Q2 2019 | $28,000 | +1300.0% | 5,874 | +1074.8% | 0.00% | – |
| Q1 2019 | $2,000 | -77.8% | 500 | -86.2% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | 0.0% | 3,623 | +111.3% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | +800.0% | 1,715 | +784.0% | 0.00% | – |
| Q1 2018 | $1,000 | -95.8% | 194 | -95.4% | 0.00% | -100.0% |
| Q3 2017 | $24,000 | +2300.0% | 4,180 | +1495.4% | 0.00% | – |
| Q1 2017 | $1,000 | – | 262 | +1355.6% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 18 | -99.4% | 0.00% | -100.0% |
| Q3 2016 | $6,000 | +500.0% | 3,199 | +593.9% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 461 | -52.5% | 0.00% | – |
| Q1 2016 | $2,000 | +100.0% | 971 | +94.2% | 0.00% | – |
| Q2 2015 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |